Signed, Not Projected.

This week's five

1. 01

   PTC, view score card · PTC Inc. · Technology / Industrial Software

   Move before publication

   +32.3%

   On October 4 PTC signed an agreement to be acquired by Schneider Electric for 205 dollars a share in cash. The filing landed on October 5 and the stock went from 144.03 to 192.26 in one session, up 33.5 percent, then spent the next three sessions doing nothing at all: 193.00, 193.60, 193.73. That flatness is the most useful thing here. A stock pinned inside a dollar and a half for three days is not a market forming an opinion, it is a register that has changed hands to people who care about one thing, whether the deal closes. At 193.73 against a 205 dollar offer, what is left is 5.82 percent, and it is capped there, to a close the company anticipates by the third quarter of 2027. This is in the issue precisely because the 33 percent is gone. It is the clearest lesson of the week in what a signed number does to a share price, and in why a big move is not the same thing as an opportunity.

   The catalyst. On October 4, 2026 PTC Inc. entered an Agreement and Plan of Merger with Schneider Electric SE and a wholly owned merger subsidiary, under which each outstanding PTC share converts into the right to receive 205 dollars in cash. The agreement was reported on Form 8-K on October 5, 2026. The board approved the agreement and resolved to recommend it to shareholders. Closing is anticipated by the third quarter of 2027, subject to approval by holders of a majority of outstanding shares at a special meeting and to required regulatory approvals, and PTC owes Schneider Electric a 700 million dollar termination fee in certain scenarios. The shares closed at 193.73 on October 8 against 146.47 on October 1 and 144.03 on October 2. U.S. Securities and Exchange Commission, October 5, 2026

   Why it made the five. Three things put this ahead of the rest of the screen. The cause is not in dispute: a regulatory filing, a stated price and a single session. The move is also almost entirely company specific, because technology as a sector finished the week flat at minus 0.02 percent, so none of this is a sector tailwind. And it is the one pick that teaches something a reader can use every week rather than only this week. Most people see a 33 percent gap and feel they have missed something. The arithmetic says the opposite: the gap is the market pricing the offer in full, and the remainder is the fee for carrying deal risk for eleven months.

   What to watch next. A shareholder vote at a special meeting, and antitrust clearance in more than one jurisdiction. No meeting date has been set, and the company anticipates closing by the third quarter of 2027 Confirms the thesis: Clearances progress and the spread to 205 dollars narrows toward the cost of waiting Breaks it: A regulator opens an in depth review, which widens the spread and puts the 144.03 pre announcement price back in play

   The case against it. The asymmetry is the whole bear case and it is severe. The upside is 5.82 percent, fixed. The downside, if the deal breaks, is a return toward the 144.03 close of October 2, roughly 26 percent below where the stock sits now. So a reader is risking about four and a half points of loss for every point of gain, on an outcome decided by regulators and a shareholder vote rather than by the business. The deal is also large and cross border, at 22.6 billion dollars, which invites review in more than one jurisdiction, and the timeline runs to the third quarter of 2027, which is a long time for anything to go wrong. The 700 million dollar termination fee protects Schneider Electric, not the shareholder.

   Weekly move (before publication): +32.3%

   Every PTC appearance →Track this pick on the Scoreboard →Size a position in it →

2. 02

   OPCH, view score card · Option Care Health, Inc. · Health Care / Home Infusion Services

   Move before publication

   +37.5%

   The same structure as PTC, one day later and with tighter numbers, which is what makes the pair worth reading together. On October 6 Option Care Health agreed to be acquired for 32.05 dollars a share in cash by Clayton Dubilier and Rice, holding about 51 percent, alongside McKesson at about 49 percent, at an enterprise value near 5.8 billion dollars. The stock went from 23.37 to 31.00 in one session, up 32.6 percent, then printed 31.01 and 31.05. At 31.05 the remaining return is 3.22 percent, to a close expected in the first half of 2027. Compare that with PTC: 5.82 percent to a later close. The wider spread is not the better deal. It is the market charging more for a bigger, slower transaction with more regulators in it, and seeing those two numbers side by side is the fastest way to understand how deal risk actually gets priced.

   The catalyst. On October 6, 2026 Option Care Health announced a definitive agreement under which Clayton Dubilier and Rice and McKesson Corporation will acquire the company for 32.05 dollars per share in cash, reflecting an enterprise value of approximately 5.8 billion dollars. The private equity buyer will hold roughly 51 percent and McKesson roughly 49 percent. The price represents a premium of about 37 percent to the October 5 closing price of 23.37 dollars. Closing is expected in the first half of 2027 and requires shareholder approval and regulatory clearances. Option Care Health provides home and alternate site infusion services across all 50 states and will remain a separate company led by its own management. The shares closed at 31.05 on October 8 against 22.58 on October 1. U.S. Securities and Exchange Commission, October 6, 2026

   Why it made the five. It earns its place for the contrast rather than for the return. Health Care rose 1.18 percent on the week and lagged the index, so this is a 37.51 percent move with no sector help at all, which is exactly the profile the screen is built to find. It also gives the issue a second, independent reading on the same question. One cash deal tells you a price. Two cash deals with different spreads and different closing dates tell you what the market thinks the risks are worth, and that comparison is information a single name cannot give.

   What to watch next. A shareholder vote and regulatory clearances, with closing expected in the first half of 2027. No meeting date has been set, and third quarter results are expected late October though the company has not announced a date Confirms the thesis: Clearance proceeds without a second request and the spread grinds toward the 32.05 dollar offer Breaks it: A financing problem at the private equity buyer or a regulator objecting to a large distributor taking 49 percent of a national infusion network

   The case against it. Worse asymmetry than PTC: 3.22 percent of upside against roughly 25 percent of downside to the 23.37 close of October 5. There is also a risk here that PTC does not carry. A private equity led buyout depends on financing that has to be raised, where a corporate acquirer pays from its own balance sheet, so a sharp tightening in credit is a direct threat to this deal and not merely a market event. And the regulatory question is pointed rather than routine: McKesson is already one of the largest pharmaceutical distributors in the country, and taking 49 percent of a home infusion network operating in all 50 states is the kind of vertical combination that attracts a closer look. A reader should also notice that the company will remain separately managed, which is the structure, not a reassurance about the outcome.

   Weekly move (before publication): +37.5%

   Every OPCH appearance →Track this pick on the Scoreboard →Size a position in it →

3. 03

   MPC, view score card · Marathon Petroleum Corporation · Energy / Refining

   Next date

   Nov 3

   The one pick in this issue whose number nobody signed. Marathon Petroleum rose 10.28 percent on the week, and 4.77 percent of it on October 8, on a refining margin rather than an agreement. The Energy Information Administration reported distillate inventories near 105.1 million barrels for the week ending October 2, the lowest level for early October in a series that starts in the early 1980s, with refineries already running at 92.7 percent of capacity and September retail diesel averaging 6.29 dollars a gallon. Then Hurricane Isaias shut in roughly 512,000 barrels a day of Gulf production, about a quarter of the offshore total. The detail that matters is that crude itself did not drive this: the crude fund USO fell 1.63 percent over the same window. This was about what refiners earn turning oil into diesel, in a market with no inventory cushion left.

   The catalyst. The Energy Information Administration reported distillate inventories near 105.1 million barrels for the week ending October 2, 2026, the lowest level for early October in a series beginning in the early 1980s, with refinery utilization rising 0.2 percentage points to 92.7 percent of operable capacity. Its October Short Term Energy Outlook recorded September retail gasoline averaging 4.35 dollars per gallon and diesel 6.29 dollars per gallon, attributed to higher crude prices and rising crack spreads. Hurricane Isaias then shut in roughly 512,000 barrels per day of Gulf offshore production, about 25 percent of the total, with six refineries representing about 14 percent of United States capacity in or near the projected path, Marathon's Garyville plant at 617,000 barrels per day the largest among them. The shares closed at 463.34 on October 8 against 420.15 on October 1, while the crude fund USO fell 1.63 percent over the same window. U.S. Energy Information Administration, October 7, 2026

   Why it made the five. It is the only name in the issue with an uncapped outcome, which is why it is here alongside two deal spreads that cannot go up. The move also survives the test the screen cares about most: Energy rose 4.05 percent as a sector, so roughly six points of this are specific to refining rather than to the oil price, and the crude fund falling over the same week rules out the simple explanation. Low inventories, high utilization and a supply interruption is the clearest version of a margin story there is, and the data behind it comes from a government release rather than from anybody's forecast.

   What to watch next. Nov 3: Third quarter results and an 11 a.m. Eastern call on November 3, announced by the company. Before that, Hurricane Isaias is forecast to make landfall the night of October 9 Confirms the thesis: Garyville comes through the storm intact and the quarter captures the wide margins the inventory data implies Breaks it: Storm damage at Garyville, or a distillate rebuild that narrows the margin before the quarter is in the bank

   The case against it. This is the sharpest risk in the issue and it resolves almost immediately. Marathon's Garyville refinery, at 617,000 barrels a day the largest plant named in the storm's projected path, sits in the track of a hurricane forecast to make landfall the night this issue is delivered. The market has spent the week paying for the margin that refinery outages create and discounting the chance that this particular company owns one of the refineries that goes down. That can be right, because an outage at a competitor widens the spread further. It can also be badly wrong. A 10.28 percent move ahead of a landfall is not a de risked position, it is a bet with a deadline, and a distillate rebuild once the storm passes would take the margin back as quickly as the storm gave it.

   Every MPC appearance →Track this pick on the Scoreboard →Size a position in it →

4. 04

   CEG, view score card · Constellation Energy Corporation · Utilities / Nuclear Generation

   Move before publication

   +10.1%

   This is the name that explains the week. On October 6 Constellation Energy and Google announced a 20 year power purchase agreement bringing 890 megawatts of new nuclear capacity onto the PJM grid, built through uprates at 11 of Constellation's reactors in Illinois, Pennsylvania and New Jersey, with Constellation committing more than 4.3 billion dollars of its own capital and first delivery expected in 2028. A separate 15 year agreement covers another 2,700 megawatts from the existing fleet. It is the largest uprate deal ever struck between a power producer and a technology company, and the stock rose 12.25 percent that day. Two sessions later it fell 4.85 percent, giving back about 40 percent of that gain, because the Financial Times reported that a different company, one that is not a counterparty to any of this, had been counting its revenue differently than investors assumed. Not one word of the agreement changed.

   The catalyst. On October 6, 2026 Google and Constellation Energy announced a 20 year power purchase agreement to bring 890 megawatts of new nuclear capacity onto the PJM Interconnection grid, generated through turbine, steam generator and digital control system upgrades at 11 Constellation nuclear units in Illinois, Pennsylvania and New Jersey. Constellation is committing more than 4.3 billion dollars to fund the build out, with the first uprate expected to be delivered by 2028, and the work is expected to sustain roughly 4,400 existing jobs and create about 7,200 construction jobs. The companies also entered a separate 15 year energy supply agreement covering an additional 2,700 megawatts from Constellation's existing PJM fleet. The shares rose from 267.62 on October 5 to 300.40 on October 6, then closed at 285.07 on October 8 against 258.92 on October 1. Google, October 6, 2026

   Why it made the five. It made the five because it is the cleanest natural experiment the week offered. A company signed a contract on Tuesday and lost a fifth of the resulting gain on Thursday on news about somebody else's accounting, which separates what a business earns from what a theme is worth more precisely than any argument could. Utilities rose 3.50 percent as a sector, so about six and a half points of this are the agreement rather than the sector. It is also the name my forward call this week is built on, which means a reader can check my reasoning against a published number rather than take it on trust.

   What to watch next. Third quarter results expected in early November, though the company has not announced a date. Before that, September CPI on October 14 is the nearer test for every rate sensitive name in the sector Confirms the thesis: The stock holds above its 267.62 close of October 5, meaning the market still prices the agreement at something Breaks it: A slide back through the pre announcement level, which would say the market has decided contracted 2028 capacity is worth nothing if the demand behind it is in question

   The case against it. Two things cut against it, and the second is the serious one. The 4.3 billion dollars is Constellation's own capital commitment, money it spends, not money it receives, and the capacity does not arrive until 2028, so a reader buying now is paying today for generation that does not exist yet against a contract that does. The deeper problem is that October 8 proved this stock trades on sentiment about artificial intelligence spending that the company cannot control. If the market is beginning to reprice that spending in general rather than one company's revenue line, a signed contract offers less protection than it looks like, because what gets marked down is the 2028 demand that justifies the build, not the 2026 signature that sold it. Sector labels hid this all week: utilities looked defensive and its data centre power names fell between 2 and 6 percent in a single session.

   Weekly move (before publication): +10.1%

   Every CEG appearance →Track this pick on the Scoreboard →Size a position in it →

5. 05

   STZ, view score card · Constellation Brands, Inc. · Consumer Staples / Beverages

   Move before publication

   +9.4%

   The only earnings driven name in the issue, and the one with a catch worth learning. Constellation Brands reported second quarter fiscal 2027 results after the close on October 6: net sales of 2,633 million dollars, up 6 percent, comparable earnings of 3.74 dollars a share against a 3.56 dollar consensus, beer net sales up about 5 percent and beer shipment volumes up 5.5 percent, with 400 million dollars returned through buybacks and dividends. The stock rose 2.35 percent on October 7 and another 4.43 percent on October 8, finishing the week up 9.42 percent. The catch is underneath the beat. Depletions, which measure what distributors actually sell on to retailers, fell 0.6 percent, with Modelo Especial down about 2 percent and Corona Extra down about 5 percent. Shipments growing 5.5 percent while depletions fall means the quarter put beer into the distribution channel rather than into anybody's fridge.

   The catalyst. Constellation Brands reported second quarter fiscal 2027 results after the close on October 6, 2026. Net sales were 2,633 million dollars, up 6 percent, comparable operating income was 897 million dollars, up 1 percent, and comparable earnings were 3.74 dollars per share, up 3 percent, against a consensus near 3.56 dollars on 2.54 billion dollars of revenue. Beer net sales rose about 5 percent to roughly 2.47 billion dollars with shipment volumes up 5.5 percent, and the company was the largest dollar share gainer in beverage alcohol for the quarter. Depletions slipped 0.6 percent, with Modelo Especial down about 2 percent and Corona Extra down about 5 percent, and management described the United States consumer as stretched. The company returned an additional 400 million dollars through share repurchases and dividends. The shares closed at 123.63 on October 8 against 112.99 on October 1. Constellation Brands, Inc., October 6, 2026

   Why it made the five. It belongs in the five because it is the week's leadership in one company. Consumer staples was the second best sector at 3.85 percent, which almost never happens in a week the index makes a new high, and this is the staples name with an actual dated event behind the move rather than a defensive bid. Roughly five and a half points of the 9.42 percent are company specific. It also sits directly across from the September labour data: a beverage company gaining dollar share while management calls the consumer stretched is the most informative kind of staples result there is.

   What to watch next. Third quarter fiscal 2027 results expected in early January, though the company has not announced a date. The nearer reading is the next distributor depletion update, which is where a channel build shows up first Confirms the thesis: Depletions turn positive and shipments stay close to them, which would make this quarter a timing effect Breaks it: Depletions fall again while shipments slow to match, which turns the channel inventory into a drag on the next two quarters

   The case against it. The market has priced the depletion number as noise, and it may not be. A 9.42 percent move on a 5 percent earnings beat says investors read the shipment growth as demand, when the two largest brands in the portfolio went backwards at the point of sale. Channel inventory is borrowed revenue: it has to be sold through eventually, and if it is not, the next quarter absorbs it. Margin is the second warning. Comparable operating income rose 1 percent against net sales up 6 percent, so the growth cost something to buy. And management's own description of a stretched United States consumer sits badly with a week in which September payrolls came in at 29,000 and unemployment rose to 4.2 percent. There was also no guidance raise alongside the beat, which is a weaker configuration than the headline suggests.

   Weekly move (before publication): +9.4%

   Every STZ appearance →Track this pick on the Scoreboard →Size a position in it →